
Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response
Keywords: Palbociclib; HCC; CCA; Radiosensitivity; PP5; ATM;